Weixin Bei
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and prognostic model development of immune checkpoint inhibitor rechallenge in recurrent or metastatic nasopharyngeal carcinoma: a real-world study.
Journal: Cancer immunology, immunotherapy : CII
Published: September 09, 2025
Single-cell transcriptome analysis reveals evolving tumour microenvironment induced by immunochemotherapy in nasopharyngeal carcinoma.
Journal: Clinical and translational medicine
Published: May 09, 2024
Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.
Journal: Oral oncology
Published: March 21, 2024
Efficacy and Safety of Re-Challenging PD-1 Inhibitors in Second-Line Treatment in Metastatic Nasopharyngeal Carcinoma Previously Treated with Chemotherapy and PD-1 Inhibitors.
Journal: Cancer management and research
Published: January 22, 2024
Anti-PD1 rechallenge in combination with anti-angiogenesis or anti-EGFR treatment beyond progression in recurrent/metastatic nasopharyngeal carcinoma patients.
Journal: Critical reviews in oncology/hematology
Published: May 18, 2023
Combination strategy exploration for prior treated recurrent or metastatic nasopharyngeal carcinoma in the era of immunotherapy.
Journal: Scientific reports
Published: May 17, 2023
Lamin A buffers CK2 kinase activity to modulate aging in a progeria mouse model.
Journal: Science advances
Published: September 25, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026